tert-butyl 4-(4-cyano-3-methylphenyl)piperidine-1-carboxylate | 675107-00-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: tert-butyl 4-(4-cyano-3-methylphenyl)piperidine-1-carboxylate
• 英文别名: Tert-butyl 4-(4-cyano-3-methylphenyl)piperidine-1-carboxylate
• CAS: 675107-00-3
• 化学式: C₁₈H₂₄N₂O₂
• 分子量: 300.401
• InChiKey: AYQZERQPACFMOH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  22
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  53.3
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  tert-butyl 4-(4-cyano-3-methylphenyl)-3,6-dihydropyridine-1(2H)-carboxylate 在 palladium 10% on activated carbon 氢气 作用下， 以 乙酸乙酯 为溶剂， 20.0 ℃ 、101.33 kPa 条件下， 反应 0.67h， 以99%的产率得到tert-butyl 4-(4-cyano-3-methylphenyl)piperidine-1-carboxylate
  参考文献：
  名称：

  [EN] IMIDAZOLIDINEDIONE-DERIVATIVES AND THEIR USE AS METALLOPROTEINASE INHIBITORS
  [FR] DERIVES D'IMIDAZOLIDINEDIONE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE METALLOPROTEINASE

  摘要：

  本发明提供了具有式中R1、G1和G2定义的含义的化合物；它们的制备方法；包含它们的药物组合物；制备所述药物组合物的方法；以及它们在治疗中的用途。

  公开号：

  WO2004024718A1

文献信息

• 1,2,4-OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE
  申请人：Giulio Matassa Victor

  公开号：US20110311485A1

  公开（公告）日：2011-12-22

  The present disclosure relates to 1, 2, 4 oxadiazole derivatives of formula (I) as well as pharmaceutical compositions comprising them, and their use in therapy as agonists of the S1P1 receptors.

  本公开涉及公式（I）的1,2,4-噁二唑衍生物，以及包含它们的药物组合物，以及它们作为S1P1受体激动剂在治疗中的使用。
• [EN] 1, 2, 4 -OXADIAZOLE DERIVATIVES AND THEIR THERAPEUTIC USE<br/>[FR] DÉRIVÉS DE 1,2,4-OXADIAZOLE ET LEUR UTILISATION THÉRAPEUTIQUE
  申请人：ALMIRALL SA

  公开号：WO2010072352A1

  公开（公告）日：2010-07-01

  New derivatives of general formula (I), or pharmaceutically acceptable salts or N- oxides thereof wherein,either (i) A is selected from the group consisting of -N-, -O- and -S-; B and C are independently selected from the group consisting of -N- and -O-, with the proviso that two of A, B and C are nitrogen atoms, or (ii) two of A, B and C are -N- and one of A, B and C is -NH-; G1 is selected from the group consisting of -CH2-, -NH- and -O-; G2 is selected from the group consisting of -NR4- and -O-; R1 represents: > a 8 to 10 membered bicyclic N-containing heteroaryl group optionally substituted with a C1-4 carboxyalkyl group or a C1-4 aminoalkyl group, > a pyridyl group optionally substituted with one or more substituents selected from hydroxy groups, C1-4 alkyl groups, C1-4 carboxyalkyl groups, C1-4 haloalkyl groups, C1-4 alkoxy groups, amino groups, C1-4 aminoalkyl groups and C1-4 aminoalkoxy groups, > a pyridone group substituted with one or more C1-4 alkyl groups; C1-4 haloalkyl groups or C1-4 aminoalkyl groups, or > a group of formula:
• [EN] IMIDAZOLIDINEDIONE-DERIVATIVES AND THEIR USE AS METALLOPROTEINASE INHIBITORS<br/>[FR] DERIVES D'IMIDAZOLIDINEDIONE ET LEUR UTILISATION EN TANT QU'INHIBITEURS DE METALLOPROTEINASE
  申请人：ASTRAZENECA AB

  公开号：WO2004024718A1

  公开（公告）日：2004-03-25

  The invention provides compounds of formula in which R1, G1 and G2 have the meanings defined in the specification; processes for their preparation; pharmaceutical compositions containing them; a process for preparing the pharmaceutical compositions; and their use in therapy.

  本发明提供了具有式中R1、G1和G2定义的含义的化合物；它们的制备方法；包含它们的药物组合物；制备所述药物组合物的方法；以及它们在治疗中的用途。